FDA 483 - Athena GTX Inc. - April 21, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Athena GTX Inc. in Johnston, IA, identified two significant observations. The firm lacked adequate procedures for monitoring and controlling process parameters, specifically for verifying unique device identifier (UDI) or universal product code (UPC) information. Additionally, procedures for receiving, reviewing, and evaluating complaints were not adequately established, with a specific SOP missing instructions for evaluating Medical Device Reportability.
ID · dbb2741e-5d49-40e7-9ca6-4601e4a8d15b